Obesity. Overweight and obesity
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Men Body mass index from 25 to 35 kilogram per square meter All persons with at least 25 percent body fat Inactive Age 18 to 35 years
Exclusion criteria
Exclusion criteria: Smoking Having an underlying disease Blood Glucose above 110 mg per liter; Hematocrit below 35% Hemoglobin below 13 g/dl WBC count more than 11,000 per microliter
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum tumor necrosis factor alpha (TNFa). Timepoint: At the beginning of the study, six weeks after the start of the supplement and exercises and 30 minutes after the end of the last training session. Method of measurement: Using ELISA method and kit made in Germany (LDN company).;Serum high-sensitivity C-reactive protein (hs-CRP). Timepoint: At the beginning of the study, six weeks after the start of the supplement and exercises and 30 minutes after the end of the last training session. Method of measurement: Using ELISA method and kit made in Germany (LDN company).;Serum interleukin 10. Timepoint: At the beginning of the study, six weeks after the start of the supplement and exercises and 30 minutes after the end of the last training session. Method of measurement: Using ELISA method and kit made in Germany (LDN company).;Serum Malondialdehyde (MDA). Timepoint: At the beginning of the study, six weeks after the start of the supplement and exercises and 30 minutes after the end of the last training session. Method of measurement: Using Fluorometric method and kit made in Iran (KPG company).;Serum total antioxidant capacity. Timepoint: At the beginning of the study, six weeks after the start of the supplement and exercises and 30 minutes after the end of the last training session. Method of measurement: Using Fluorometric method and kit made in Iran (KPG company). | — |
Secondary
| Measure | Time frame |
|---|---|
| Body Composition. Timepoint: At the beginning of the study and six weeks after the start of the supplement and training. Method of measurement: Using inbody 770 machine.;High Density Lipoprotein (HDL). Timepoint: At the beginning of the study and six weeks after the start of the supplement and training. Method of measurement: Using Hitachi 717 machine and kit made in Iran.;Low Density Lipoprotein (LDL). Timepoint: At the beginning of the study and six weeks after the start of the supplement and training. Method of measurement: Using Hitachi 717 machine and kit made in Iran.;Triglyceride (TG). Timepoint: At the beginning of the study and six weeks after the start of the supplement and training. Method of measurement: Using Hitachi 717 machine and kit made in Iran.;Cholesterol. Timepoint: At the beginning of the study and six weeks after the start of the supplement and training. Method of measurement: Using Hitachi 717 machine and kit made in Iran. | — |
Countries
Iran (Islamic Republic of)
Contacts
The University of Shahid Beheshti